November 2023 Price Concessions – Final Update
THIS CONTENT HAS NOW EXPIRED
Following discussions between Community Pharmacy England and the Department of Health and Social Care (DHSC) regarding medicine pricing issues reported by pharmacy owners, the Department has today (30/11/2023) announced the following final list of price concessions for November 2023:
Please note the following two lines have been revised upwards following mid-month price changes reported by pharmacy owners, the revised prices are reflected in the table below:
- Co-codamol 30mg/500mg capsules
- Etoricoxib 60mg tablets
Drug | Pack size | Price concession |
Amisulpride 100mg tablets | 60 | £14.94 |
Azithromycin 250mg capsules | 6 | £1.59 |
Beclometasone 50micrograms/dose nasal spray | 200 | £2.60 |
Betahistine 8mg tablets | 84 | £3.80 |
Betamethasone valerate 0.1% cream | 100 | £4.05 |
Bimatoprost 100micrograms/ml eye drops | 3 | £3.95 |
Bimatoprost 300micrograms/ml / Timolol 5mg/ml eye drops | 3 | £4.58 |
Carbocisteine 250mg/5ml oral solution | 300 | £7.00 |
Chlorphenamine 2mg/5ml oral solution sugar free | 150 | £4.87 |
Clarithromycin 125mg/5ml oral suspension | 70 | £4.32 |
Clarithromycin 250mg/5ml oral suspension | 70 | £5.65 |
Co-amoxiclav 250mg/62mg/5ml oral suspension sugar free | 100 | £2.04 |
Co-amoxiclav 500mg/125mg tablets | 21 | £3.46 |
Co-codamol 30mg/500mg capsules | 100 | £4.50 |
Co-codamol 30mg/500mg tablets | 30 | £1.20 |
Co-codamol 30mg/500mg tablets | 100 | £4.00 |
Colecalciferol 1,000unit capsules | 30 | £6.31 |
Cyclizine 50mg tablets | 100 | £4.35 |
Donepezil 5mg tablets | 28 | £1.99 |
Dorzolamide 20mg/ml / Timolol 5mg/ml eye drops | 5 | £5.07 |
Eplerenone 25mg tablets | 28 | £6.43 |
Estradiol 10microgram pessaries | 24 | £9.45 |
Etoricoxib 60mg tablets | 28 | £2.99 |
Ezetimibe 10mg tablets | 28 | £9.44 |
Fluticasone 400microgram/unit dose nasal drops | 28 | £14.92 |
Frovatriptan 2.5mg tablets | 6 | £11.32 |
Haloperidol 1.5mg tablets | 28 | £3.28 |
Latanoprost 50micrograms/ml / Timolol 5mg/ml eye drops | 2.5 | £11.76 |
Lorazepam 500microgram tablets | 28 | £20.04 |
Mebeverine 50mg/5ml oral suspension sugar free | 300 | £210.43 |
Memantine 10mg/ml oral solution sugar free | 50 | £24.18 |
Metoprolol 50mg tablets | 28 | £3.24 |
Midazolam 10mg/2ml solution for injection ampoules | 10 | £5.15 |
Morphine sulfate 10mg/1ml solution for injection ampoules | 10 | £5.82 |
Oxycodone 5mg/5ml oral solution sugar free | 250 | £9.34 |
Pantoprazole 40mg gastro-resistant tablets | 28 | £3.16 |
Pyridostigmine bromide 60mg tablets | 200 | £23.48 |
Quinine sulfate 300mg tablets | 28 | £3.99 |
Riluzole 50mg tablets | 56 | £216.45 |
Ropinirole 2mg tablets | 28 | £21.56 |
Ropinirole 500microgram tablets | 28 | £15.75 |
Sitagliptin 100mg/5ml oral solution sugar free | 150 | £57.56 |
Sodium chloride 0.9% nebuliser liquid 2.5ml unit dose ampoules | 20 | £9.50 |
Tacrolimus 0.1% ointment | 30 | £20.03 |
Tacrolimus 0.1% ointment | 60 | £37.05 |
Telmisartan 20mg tablets | 28 | £3.37 |
For the full list of price concessions granted for November 2023, please visit our webpage: cpe.org.uk/priceconcessions
No additional endorsements are required for price concessions. A price concession only applies for the month it is granted; any prices agreed for concessions requested late in the month will roll over into the following month.
Please subscribe to our mailing list to receive email updates of any price concessions.
Further information on price concessions and FAQs about the process involved can be found on our website (cpe.org.uk/priceconcessions) To hear more on how the current price concessions system operates, pharmacy teams can now access a recording of our recent Medicines Supply and Concessions Briefing webinar here.
Improvements to the price concession system
Following significant concerns raised by pharmacies about the unsustainable level of prices imposed by DHSC in second half of 2022, it was agreed that an urgent review of the price concession setting system would take place.
Since this announcement, we have sent a strong and clear message back to Government that pharmacies cannot continue to subsidise the NHS medicines bill. Following the review of the concessionary price process, a package of measures has been developed to improve the system.
One of the solutions agreed between us and DHSC is that from 1st April 2023, all products granted a concessionary price will be classified as ‘Discount Not Deducted’ for the month(s) in which they are on concession.
Furthermore, from May 2023, DHSC has implemented a process to roll over prices to the following month for any concessions requested after the 23rd of the month provided these prices were agreed with us. We are also continuing to work with DHSC on how a ‘retrospective increased payment’ may apply, where appropriate. Further information regarding this concession ‘top-up’ mechanism will be issued once details are finalised.